Ultimately, STAT3, SRC, MAPK3, MAPK1, RELA, PTPN11, JUN, MAPK14, STAT1, and EGFR were identified as the core targets of YTG for the treatment of IPF (Table 2). This evidence concerns the gene STAT3 and idiopathic pulmonary fibrosis.